Impact of documented penicillin allergy label on clinical outcomes and antibiotic utilization in adults with HIV and subsequent bacterial pneumonia
Background Penicillin allergy labels (PAL) are reported in approximately 10% of the US population but reflect true IgE-mediated allergy in only 1–2%. PALs have been associated with broader-spectrum antibiotic use and adverse outcomes in general populations. The impact of PAL in people living with HIV (PWH) diagnosed with bacterial pneumonia has not been characterized. Methods A retrospective propensity score–matched cohort study was conducted using the TriNetX US Collaborative Network. Adults with HIV and a diagnosis of bacterial pneumonia were stratified by a documented PAL. 1:1 greedy nearest-neighbor matching balanced demographics, comorbidities, and CD4 strata. Antibiotic utilization at 30 days and clinical outcomes at 30 and 90 days were compared using risk ratios, Cox proportional-hazards models, and Kaplan–Meier survival analysis. Results After matching, PAL subjects had markedly lower penicillin exposure (11.8% vs. 26.4%; RR 0.45, p < 0.001) and significantly higher exposure to alternative antibiotics. At 30 days, PAL patients had increased risks for hospitalization (RR=1.205, 95%CI: 1.145-1.269) and intensive care services (RR=1.170, 95%CI: 1.004-1.365). At 90 days, higher rates of hospitalization (RR=1.195, 95%CI: 1.139-1.254), intensive care utilization (RR=1.352, 95%CI: 1.169-1.562), acute respiratory failure (RR=1.150, 95%CI: 1.043-1.267), mechanical ventilation (RR=1.227, 95%CI: 1.029-1.462), and acute kidney injury (RR=1.171, 95%CI: 1.030-1.332) were seen in the PAL group. Conclusions In PWH diagnosed with bacterial pneumonia, a PAL was associated with altered antibiotic prescribing and worse clinical outcomes, supporting proactive allergy delabeling as a high-yield stewardship intervention in HIV care.
Authors
- Eric G. Sahloff (ORCID: https://orcid.org/0000-0003-2132-615X)
- Hunter Eby (ORCID: https://orcid.org/0000-0002-9029-9768)
- Joan M. Duggan (ORCID: https://orcid.org/0000-0002-3049-2355)
- Brayden J. Seliger
Institutions
- University of Toledo (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1093/ofid/ofag756
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00